Literature DB >> 28794999

Modulation of the p53 family network by RNA-binding proteins.

Chris Lucchesi1, Jin Zhang1, Xinbin Chen1.   

Abstract

Since its discovery more than three decades ago, tumor suppressor p53 has been shown to play pivotal roles in both maintaining genomic integrity and tumor suppression. p53 functions as a transcription factor responding to a multitude of cellular stressors, regulating the transcription of many genes involved in cell-cycle arrest, senescence, autophagy, and apoptosis. Extensive work has revealed that p53 is one of the most commonly mutated tumor suppressor genes. The last three decades have demonstrated that p53 activity is controlled through transcriptional regulation and posttranslational modifications. However, evolving work is now uncovering that p53, and other p53 family members, are post-transcriptionally regulated by multiple RNA-binding proteins (RBPs). Understanding the regulation of p53 by RBPs may potentially open up the possibility for cancer therapeutic intervention. This review focuses on the posttranscriptional regulation of p53, and p53 family members, by RNA binding proteins and the reciprocal feedback pathways between several RNA-biding proteins modulating p53, and p53 family members.

Entities:  

Keywords:  RNA-binding proteins (RBPs); Rbm38; p53; post-transcriptional regulation

Year:  2016        PMID: 28794999      PMCID: PMC5546219          DOI: 10.21037/tcr.2016.08.30

Source DB:  PubMed          Journal:  Transl Cancer Res        ISSN: 2218-676X            Impact factor:   1.241


  97 in total

1.  Deacetylation of p53 modulates its effect on cell growth and apoptosis.

Authors:  J Luo; F Su; D Chen; A Shiloh; W Gu
Journal:  Nature       Date:  2000-11-16       Impact factor: 49.962

2.  RNA-binding Protein PCBP2 Regulates p73 Expression and p73-dependent Antioxidant Defense.

Authors:  Cong Ren; Jin Zhang; Wensheng Yan; Yanhong Zhang; Xinbin Chen
Journal:  J Biol Chem       Date:  2016-02-23       Impact factor: 5.157

3.  p53 mutant mice that display early ageing-associated phenotypes.

Authors:  Stuart D Tyner; Sundaresan Venkatachalam; Jene Choi; Stephen Jones; Nader Ghebranious; Herbert Igelmann; Xiongbin Lu; Gabrielle Soron; Benjamin Cooper; Cory Brayton; Sang Hee Park; Timothy Thompson; Gerard Karsenty; Allan Bradley; Lawrence A Donehower
Journal:  Nature       Date:  2002-01-03       Impact factor: 49.962

4.  Amplification of a gene encoding a p53-associated protein in human sarcomas.

Authors:  J D Oliner; K W Kinzler; P S Meltzer; D L George; B Vogelstein
Journal:  Nature       Date:  1992-07-02       Impact factor: 49.962

5.  Nucleocytoplasmic shuttling of oncoprotein Hdm2 is required for Hdm2-mediated degradation of p53.

Authors:  W Tao; A J Levine
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

6.  p73 in Cancer.

Authors:  Alessandro Rufini; Massimiliano Agostini; Francesca Grespi; Richard Tomasini; Berna S Sayan; Maria Victoria Niklison-Chirou; Franco Conforti; Tania Velletri; Antonio Mastino; Tak W Mak; Gerry Melino; Richard A Knight
Journal:  Genes Cancer       Date:  2011-04

7.  HDM2 protein overexpression, but not gene amplification, is related to tumorigenesis of cutaneous melanoma.

Authors:  D Polsky; B C Bastian; C Hazan; K Melzer; J Pack; A Houghton; K Busam; C Cordon-Cardo; I Osman
Journal:  Cancer Res       Date:  2001-10-15       Impact factor: 12.701

8.  RNA-binding protein RBM24 regulates p63 expression via mRNA stability.

Authors:  Enshun Xu; Jin Zhang; Min Zhang; Yuqian Jiang; Seong-Jun Cho; Xinbin Chen
Journal:  Mol Cancer Res       Date:  2013-12-27       Impact factor: 5.852

9.  MDM2 expression is repressed by the RNA-binding protein RNPC1 via mRNA stability.

Authors:  E Xu; J Zhang; X Chen
Journal:  Oncogene       Date:  2012-06-18       Impact factor: 9.867

10.  Dissecting the expression landscape of RNA-binding proteins in human cancers.

Authors:  Bobak Kechavarzi; Sarath Chandra Janga
Journal:  Genome Biol       Date:  2014-01-10       Impact factor: 13.583

View more
  5 in total

1.  Survivin Expression Is Differentially Regulated by a Selective Cross-talk between RBM38 and miRNAs let-7b or miR-203a.

Authors:  Christopher A Lucchesi; Jin Zhang; Buyong Ma; Ruth Nussinov; Xinbin Chen
Journal:  Cancer Res       Date:  2021-01-20       Impact factor: 13.312

2.  The Possible Mechanisms of HSV-TK/Hyperthermia Combined with 131I-antiAFPMcAb-GCV Nanospheres to Treat Hepatoma.

Authors:  Mei Lin; Chenglin Zhou; Junxing Huang; Weizhong Tian; Hong Yu; Xingmao Jiang; Jun Ye; Ting Guo; Yujuan Shi; Yanhong Xiao; Xuefeng Bian; Xiaoqian Feng
Journal:  Anal Cell Pathol (Amst)       Date:  2018-05-03       Impact factor: 2.916

3.  NOVA1 acts as an oncogene in melanoma via regulating FOXO3a expression.

Authors:  Xin Yu; Heyi Zheng; Matthew T V Chan; William K K Wu
Journal:  J Cell Mol Med       Date:  2018-03-02       Impact factor: 5.310

4.  Reciprocal modulation of long noncoding RNA EMS and p53 regulates tumorigenesis.

Authors:  Chenfeng Wang; Yang Yang; Xianning Wu; Jingxin Li; Kaiyue Liu; Debao Fang; Bingyan Li; Ge Shan; Xinyu Mei; Fang Wang; Yide Mei
Journal:  Proc Natl Acad Sci U S A       Date:  2022-01-18       Impact factor: 12.779

Review 5.  RNA-Binding Protein Rbm24 as a Multifaceted Post-Transcriptional Regulator of Embryonic Lineage Differentiation and Cellular Homeostasis.

Authors:  Raphaëlle Grifone; Ming Shao; Audrey Saquet; De-Li Shi
Journal:  Cells       Date:  2020-08-12       Impact factor: 6.600

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.